Afaxys Pharmaceuticals Products Now Available Nationwide; OCs Placed on Pennsylvania Medicaid's Preferred Oral Contraceptives List
July 30, 2014 09:56 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Jul 30, 2014) - Three FDA-approved oral contraceptives from Afaxys Pharmaceuticals, a division of Afaxys, Inc., (www.afaxys.com/pharma) are now preferred OCs, as per...
HRA Pharma and Afaxys Join Forces on Emergency Contraceptive ella(R) in the USA
March 31, 2014 09:00 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Mar 31, 2014) - HRA Pharma (www.hra-pharma.com) and Afaxys Pharmaceuticals, a division of Afaxys, Inc. (www.Afaxys.com), announced today that the companies have...
Now Commercially Available, Lyza(TM) Creates a Stir in the Market; Public Health Providers Benefit From Low Pricing, Stable Supply
March 10, 2014 11:30 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Mar 10, 2014) - The recent commercial coverage of a new oral contraceptive signals a possible shift in the market toward low-cost pharmaceuticals. Afaxys...
Aubra(TM) Coverage Expands Significantly
February 20, 2014 12:15 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Feb 20, 2014) - Afaxys Pharmaceuticals' oral contraceptive,
Aubra™ /AW•bruh/ (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1mg/0.02mg) is an...
The Beach Company and MWV Break Ground on "Parks at Nexton"
January 20, 2014 12:00 ET
|
Nexton
SUMMERVILLE, SC--(Marketwired - Jan 20, 2014) - The Beach Company and MWV have broken ground on the 320-unit Parks at Nexton apartment community. A joint venture of the two local companies, the...
Afaxys Pharmaceuticals Introduces New Generic, Oral Contraceptive; Aubra(TM) Extends Company's Mission to Serve Safety Net Health Providers
October 29, 2013 13:15 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Oct 29, 2013) - Afaxys Pharmaceuticals, a division of Afaxys, Inc. (afaxys.com), is dedicated to providing affordable health care products to the public health care...
Afaxys Pharmaceuticals Products Now Available on MMCAP Contract, Securing Affordable OCs for Their Membership
September 04, 2013 08:24 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Sep 4, 2013) - Afaxys Pharmaceuticals, a division of Afaxys, Inc., (www.afaxys.com/pharma) received FDA approval for two new oral contraceptives earlier this year,...
Afaxys Pharmaceuticals Introduces New Generic, Oral Contraceptive
July 22, 2013 13:15 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Jul 22, 2013) - Afaxys Pharmaceuticals, a division of Afaxys, Inc. (www.afaxys.com), is dedicated to providing affordable health care products to the public health...
Chateal Coverage Expands Significantly
July 01, 2013 16:58 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Jul 1, 2013) - Afaxys Pharmaceuticals' oral contraceptive, CHATEAL® \shah•TEEL\ (Levonorgestrel and Ethinyl Estradiol tablets USP, 0.15 mg/0.03mg) is...
Now Commercially Available, CHATEAL(R) Creates a Stir in the Market; Public Health Providers Benefit From Low Pricing, Stable Supply From Afaxys Pharmaceuticals
April 24, 2013 09:00 ET
|
Afaxys Pharmaceuticals
CHARLESTON, SC--(Marketwired - Apr 24, 2013) - The recent commercial coverage of a new oral contraceptive heralds a possible shift in the market toward low-cost pharmaceuticals.
...